🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
After the Mother of All Deals: A Blueprint for the Ireland-India Pharmaceutical Corridor Under the EU-India FTA ◆ The UK-India CETA: A Deep Dive into Bilateral Pharmaceutical Value Chains, API Trade, and Medicine Price Trajectories ◆ Bilateral Breakthrough: How the Historic UK-India Free Trade Agreement Transforms Life Sciences and Key Trade Sectors ◆ Normalization or Correction? Ireland’s Goods Exports Drop 29% in May as Pharma Surplus Narrows ◆ Pilot Photonics Secures €10.4 Million EIC Accelerator Funding to Scale Deeptech Photonic Chips ◆ Intel Announces €5 Billion ($5.7 Billion) AI-Driven Semiconductor Expansion at Leixlip, Kildare ◆ University of Galway to Lead New €64.5m Research Ireland Rinn Medical Devices Centre ◆ Chanelle Pharma Renews Historic Partnership with Galway Races Summer Festival 2026 ◆ After the Mother of All Deals: A Blueprint for the Ireland-India Pharmaceutical Corridor Under the EU-India FTA ◆ The UK-India CETA: A Deep Dive into Bilateral Pharmaceutical Value Chains, API Trade, and Medicine Price Trajectories ◆ Bilateral Breakthrough: How the Historic UK-India Free Trade Agreement Transforms Life Sciences and Key Trade Sectors ◆ Normalization or Correction? Ireland’s Goods Exports Drop 29% in May as Pharma Surplus Narrows ◆ Pilot Photonics Secures €10.4 Million EIC Accelerator Funding to Scale Deeptech Photonic Chips ◆ Intel Announces €5 Billion ($5.7 Billion) AI-Driven Semiconductor Expansion at Leixlip, Kildare ◆ University of Galway to Lead New €64.5m Research Ireland Rinn Medical Devices Centre ◆ Chanelle Pharma Renews Historic Partnership with Galway Races Summer Festival 2026 ◆
Updated 29 Jul 2026 · ClinicalTrials.gov

HER2-negative Breast Cancer Trials in Ireland

← All Irish trials

Every active and recruiting clinical study with an Irish site — searchable by condition, sponsor, phase and location. Refreshed daily from the ClinicalTrials.gov registry.

1
Recruiting now
2
Active studies
Recruiting Phase 3
Elacestrant for Treating ER+/HER2- Breast Cancer Patients With ctDNA Relapse (TREAT ctDNA)
ER-positive Breast Cancer, HER2-negative Breast Cancer, Stage IIB Breast Cancer, Stage III Breast Cancer
European Organisation for Research and Treatment of Cancer - EORTC · started 2023-12-15
📍 Dublin · Waterford
NCT05512364 on ClinicalTrials.gov ↗
Active Phase 3
Sacituzumab Govitecan in Primary HER2-negative Breast Cancer
HER2-negative Breast Cancer, Triple Negative Breast Cancer
GBG Forschungs GmbH · started 2020-10-28
📍 Cork · Dublin · Limerick · Waterford
NCT04595565 on ClinicalTrials.gov ↗
No trials match your search.

Browse by location

Dublin · 81 Cork · 27 Galway · 24 Waterford · 11 Limerick · 10 Sligo · 4 Beaumont · 3 Tallaght · 2 Tralee · 1 Crumlin · 1 Balrath · 1 Rathgar · 1

Browse by condition

Breast Cancer · 7 Chronic Lymphocytic Leukemia · 5 Prostate Cancer · 5 Cancer · 4 Small Lymphocytic Lymphoma · 3 Triple Negative Breast Cancer · 3 Mantle Cell Lymphoma · 2 Follicular Lymphoma · 2 HER2-negative Breast Cancer · 2 Metabolic Disease · 2 Ulcerative Colitis · 2 Prostatic Neoplasms · 2 Coronary Artery Disease (CAD) · 2
Cite this page

Priya Life Science (2026). Clinical Trials in Ireland Tracker. Available at: https://priyalifescience.com/clinical-trials-ireland/condition/her2-negative-breast-cancer (Accessed: 29 July 2026).

Embed this data ↗

Source: ClinicalTrials.gov, U.S. National Library of Medicine — studies listing at least one Irish site, refreshed daily. Listing here is informational and not medical advice; eligibility is determined by each study team. Patients should discuss participation with their clinician. For trials across the wider EU, see our EU Clinical Trials Tracker.